Unilabs, a Swiss diagnostics company, has partnered with US-based medtech C2N Diagnostics to exclusively distribute C2N’s Alzheimer’s blood tests across the EU, including Norway, Switzerland, the U.K., Peru, Saudi Arabia, and the UAE.
CRISPR has been called one of the most exciting developments in genetic engineering. It is opening up new possibilities in medicine, particularly for discovering new types of drugs for genetic diseases and new ways of repairing and replacing organs and tissue in regenerative medicine. In an interview with HBI, Philip Hargreaves, Director of Strategic Marketing & Business Development at Promega UK, the UK branch of US biotech company Promega, spoke about how CRISPR, when combined with Promega’s innovative HiBiT technology, can accelerate the drug discovery process.
Aster DM Healthcare, a Dubai-based multinational private hospital group with operations in India’s Bengaluru, is said to be negotiating a merger with Hyderabad's Care Hospitals, one of India’s largest hospital groups. This potential merger could create India’s third largest hospital group.
Advanced Computer Software Group Ltd, the company that provided IT and software services to the NHS during the 2022 ransomware attack, may face a £6 million fine from the Information Commissioner's Office (ICO), the British data and privacy watchdog.
In this HBI News Round Up we cover global private markets manager CVC’s acquisition of diagnostic imaging company medneo UK, NHS and self-pay healthcare services provider Provide Community Group’s acquisition of Mind Professionals, Skanray Partners collaboration with Tata Elxsi to develop surgical imaging and healthcare innovation and wellness technology company TRIPP’s launch of an AI-powered meditation guide.
European PE firm Palamon Capital has hired US investment bank Morgan Stanley to advise on a potential sale of mydentist, the UK’s largest dental chain.
German multinational medtech firm Siemens Healthineers has introduced the first AI-enhanced eco-friendly multi-testing diagnostic analyser in India at diagnostic centre Mahajan Imaging & Labs.
Orchid, a US-based, behavioural health electronic health record vendor, has developed a first-of-its-kind generative AI-enabled note taking tool to support mental health providers who are struggling with the burdens of administrative tasks and help patients get the care they need faster.
London-based mid-market private equity investor Livingbridge has sold Habit Health, a leading provider of integrated rehabilitation and mental health services in New Zealand, to Australasia-based PE firm, Five V Capital.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy